APA (7th ed.) Citation

M, H., KF, E., H, K., ME, M., TI, C., WC, W., & J, N. (2026). Safety and Effectiveness of Apixaban Versus Warfarin in Peritoneal Dialysis Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation. American journal of nephrology, 1. https://doi.org/10.1159/000553428

Chicago Style (17th ed.) Citation

M, He, Erickson KF, Kassem H, Montez-Rath ME, Chang TI, Winkelmayer WC, and Niu J. "Safety and Effectiveness of Apixaban Versus Warfarin in Peritoneal Dialysis Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation." American Journal of Nephrology 2026: 1. https://doi.org/10.1159/000553428.

MLA (9th ed.) Citation

M, He, et al. "Safety and Effectiveness of Apixaban Versus Warfarin in Peritoneal Dialysis Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation." American Journal of Nephrology, 2026, p. 1, https://doi.org/10.1159/000553428.